Representatives a report that describes the conduct of the pilot program. (2) Elements The report required by paragraph (1) shall include the following: (A) A description of the pilot program, including outcome measures developed to determine the overall effectiveness of the pilot program. (B) A description of the ability of the pilot program to identify opioid misuse and abuse among beneficiaries under the TRICARE program in each pharmacy venue of the pharmacy program of the military health system. (C) A description of the impact of the use of predictive analytics to monitor such beneficiaries to identify the potential for opioid abuse and addiction before such beneficiaries begin an opioid prescription. (D) A description of any reduction in the misuse or abuse of opioid medications among such beneficiaries as a result of the pilot program. (d) Duration (1) In general Except as provided in paragraph (2), the Director shall carry out the pilot program for a period of not more than three years. (2) Expansion The Director may implement the pilot program on a permanent basis if the Director determines that the pilot program successfully reduces early opioid exposure in beneficiaries under the TRICARE program and prevents progression to misuse or abuse of opioid medications. (e) TRICARE program defined In this section, the term TRICARE program has the meaning given that term in section 1072 of title 10, United States Code. 705. Pilot program on treatment of members of the Armed Forces for post-traumatic stress disorder related to military sexual trauma (a) In general The Secretary of Defense may carry out a pilot program to assess the feasibility and advisability of using intensive outpatient programs to treat members of the Armed Forces suffering from post-traumatic stress disorder resulting from military sexual trauma, including treatment for substance abuse, depression, and other issues related to such conditions. (b) Discharge through partnerships The pilot program authorized by subsection (a) shall be carried